Giovanni Francesco Pellicanò

20PUBLICATIONS
73CO-AUTHORS
Pharmaceutical delivery technologiesCancer cell biologyFeminist theoryCancer therapy (excl. chemotherapy and radiation therapy)Behavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Nov 27, 2025
Efficacy and Safety of Cabotegravir-Rilpivirine in PLWH: A Real-World Study.

Giuseppe Nicolò Conti, Serena Spampinato, Andrea De Vito

|Aug 28, 2025
Investigating the Impact of Fusobacterium nucleatum on Oxidative Stress, Chemoresistance, and Inflammation in Inflammatory Bowel Disease and Colorectal Cancer: Rationale and Design of a Clinical Trial.

Pierluigi Consolo, Carlotta Giorgi, Concetta Crisafulli

|Jul 30, 2025
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation.

Serena Spampinato, Emmanuele Venanzi Rullo, Giuseppe Nicolò Conti

|Mar 26, 2025
The Challenging Scenario of Cancer Treatment for People with HIV: Clinical Experience with Immune Checkpoint Inhibitors.

Tindara Franchina, Patrizia Carroccio, Ylenia Russotto

|Oct 26, 2024
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort.

Agnese Colpani, Andrea De Vito, Andrea Marino

|May 25, 2024
Screening for Latent Tuberculosis Infection in People Living with HIV: TUBHIVIT Project, a Multicenter Italian Study.

Luca Pipitò, Elena Delfina Ricci, Paolo Maggi

Pageof 4

Frequent Collaborators

11 joint publications

Benedetto Maurizio Celesia

8 joint publications

Giuseppe Nunnari

7 joint publications

Emmanuele Venanzi Rullo

7 joint publications

Ylenia Russotto